BibTex format
@article{Ghafari:2026:10.1080/14760584.2026.2732508,
author = {Ghafari, M and Watson, OJ and Dascalu, S and Mon, SHH and Abeler-Dörner, L and Rezaee-Zavareh, MS and Pley, C and Kordasti, S and Abbas, K and Madani, K and Panovska-Griffiths, J},
doi = {10.1080/14760584.2026.2732508},
journal = {Expert Rev Vaccines},
title = {Global vaccine readiness: equity-by-design in pandemic preparedness and response.},
url = {http://dx.doi.org/10.1080/14760584.2026.2732508},
volume = {25},
year = {2026}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - INTRODUCTION: COVID-19 showed that rapid vaccine development and roll-out, while lifesaving, can still yield large, avoidable harms when equity is not considered from the outset. Disparities in vaccine timing and coverage, especially in low-resource settings, amplified health and economic burdens, highlighting the need for preparedness frameworks that combine speed with fairness. AREAS COVERED: We synthesize evidence from literature and policy reports regarding global vaccine roll-out, focusing on avertable mortality under alternative sharing scenarios, procurement design, pooled mechanisms such as COVAX, and the role of distributed manufacturing and delivery capacity. We also examine how transparent data-sharing, effective public communication, genomic surveillance, adaptive trial designs, and modeling hubs can support more responsive and equitable vaccine deployment. Across six reflection points, we translate these lessons into practical priorities for future pandemic readiness, including strengthening healthcare infrastructure, equitable procurement, data transparency, and safeguarding public health decision-making from political and commercial distortion. EXPERT OPINION: We argue that equity-by-design is essential if vaccine innovation is to deliver equitable public health impact. This requires geographically distributed manufacturing, transparency, equity-conditioned advance purchase agreements, and pre-agreed, epidemiology-triggered allocation of vaccines. We recommend institutionalizing disaggregated reporting, standardized data-sharing, greater pathogen genomic sequencing capacity, and communication strategies that support public health protection while countering misinformation.
AU - Ghafari,M
AU - Watson,OJ
AU - Dascalu,S
AU - Mon,SHH
AU - Abeler-Dörner,L
AU - Rezaee-Zavareh,MS
AU - Pley,C
AU - Kordasti,S
AU - Abbas,K
AU - Madani,K
AU - Panovska-Griffiths,J
DO - 10.1080/14760584.2026.2732508
PY - 2026///
TI - Global vaccine readiness: equity-by-design in pandemic preparedness and response.
T2 - Expert Rev Vaccines
UR - http://dx.doi.org/10.1080/14760584.2026.2732508
UR - https://www.ncbi.nlm.nih.gov/pubmed/42750274
VL - 25
ER -